<DOC>
	<DOCNO>NCT01069549</DOCNO>
	<brief_summary>India `` Diabetes Capital World '' 41 million Indians diabetes , every fifth diabetic world Indian type 2 Diabetes Mellitus ( T2DM ) constitute major chunk diabetes . One severe complication diabetes development diabetic nephropathy . Diabetic nephropathy ( DN ) lead cause end-stage renal disease ( ESRD ) worldwide . There many identifiable risk factor diabetic nephropathy like hyperglycemia , hyperlipidemia , hypertension , proteinuria , genetic factor main among . Long-term observational study show nearly 30-35 % type 2 diabetic patient develop nephropathy , irrespective glycemic control . The regional variation diabetes prevalence proclivity diabetes induced renal disease ; along report familial cluster nephropathy suggest possible genetic basis . The renin-angiotensin system ( RAS ) strongly implicate pathogenesis progressive renal disease . In addition , blockage angiotensin II either ACE inhibitor angiotensin type-I receptor antagonist find prevent delay progression renal injury associate diabetes 5 drug first-choice drug treatment diabetic subject hypertension . The gene encode renin-angiotensin system ( RAS ) , angiotensin-converting enzyme ( ACE ) , angiotensinogen ( AGT ) angiotensin II receptor type 1 ( AGTR1 ) , report probable candidate gene diabetic nephropathy . As data available AGTR1 polymorphism DN north Indian T2DM , attempt fill scientific gap .</brief_summary>
	<brief_title>Association AGTR1 ACACB Gene Polymorphism Diabetic Nephropathy Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>Group:1 : Patients diabetic nephropathy Inclusion criterion : Type 2 Diabetes duration equal 5 year . Age 30 85 year . Presence albuminuria retinopathy . Exclusion criterion : Patients diagnosis type 1 diabetes Any known nondiabetic renal disease . Patients MI undergone CABG within 3 month . Patients CVA undergone PTCA previous 3 month . Patients transient ischemic attack within previous 3 month . Patients history heart failure enrollment . Patients UTI . Pregnant patient . Group:2 : Patients without diabetic nephropathy Same characteristic group 1 evidence diabetic nephropathy .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Diabetic Nephropathy</keyword>
	<keyword>Angiotensin II type 1 receptor gene polymorphism</keyword>
	<keyword>Acetyl coA carboxylase beta gene polymorphism .</keyword>
</DOC>